A Novel Prognostic Nomogram Is More Accurate than Conventional Staging Systems for Predicting Survival after Resection of Hepatocellular Carcinoma

Journal of the American College of Surgeons

Volumn 206, Issue 2, 2008, Pages 281-291

  Cho, Clifford S ^a   Gonen, Mithat ^a   Shia, Jinru ^a   Kattan, Michael W ^b   Klimstra, David S ^a   Jarnagin, William R ^a   D'Angelica, Michael I ^a   Blumgart, Leslie H ^a   DeMatteo, Ronald P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGE; AGED; ARTICLE; BLEEDING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HARREL CONCORDANCE INDEX; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE;

EID: 38349105634     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.07.031     Document Type: Article

References (45)

1. Everson G.T. Increasing incidence and pretransplantation screening of hepatocellular carcinoma. Liver Transpl 6 Suppl 2 (2000) S2-S10
2. Stipa F., Yoon S.S., Liau K.H., et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 106 (2006) 1331-1338
3. Hemming A.W., Langer B., Sheiner P., et al. Aggressive surgical management of fibrolamellar hepatocellular carcinoma. J Gastrointest Surg 1 (1997) 342-346
4. Martin R.C., Jaques D.P., Brennan M.F., and Karpeh M. Achieving R0 resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?. J Am Coll Surg 194 (2002) 568-577
5. Harrell F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluation assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
6. Kattan M.W., Eastham J.A., Stapleton A.M.F., et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
7. Efron B., and Tibshirani R.J. An introduction to the bootstrap (1993), Chapman and Hall, Boca Raton, FL
8. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the esophagus for bleeding esophageal varices. Br J Surg 67 (1973) 773-775
9. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 (2000) 864-871
10. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
11. th ed. (1998), Lippincott-Raven, Philadelphia 98-126
12. Makuuchi M., Belghiti J., Belli G., et al., Working Group of the International Scientific Committee of the International Hepato-Pancreato-Biliary Association. IHPBA concordant classification of primary liver cancer: working group report. J Hepatobiliary Pancreat Surg 10 (2003) 26-30
13. th ed. (2002), Springer, New York 131-138
14. Vauthey J.N., Lauwers G.Y., Esnaola N.F., et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 20 (2002) 1527-1536
15. Okuda K., Ohtsuki T., and Obata H. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 56 (1985) 918-928
16. Llovet J.M., Bru C., and Cruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
17. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31 (2000) 840-845
18. Kudo M., Chung H., and Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38 (2003) 207-215
19. Farinati F., Rinaldi M., Gianni S., and Naccarato R. How should patients with hepatocellular carcinoma be staged?. Validation of a new prognostic system. Cancer 89 (2000) 2266-2273
20. Zhao W.H., Ma Z.M., Zhou X.R., et al. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 8 (2002) 237-242
21. Bruix J., and Llovet J.M. Prognostic assessment and evaluation of the benefits of treatment. J Clin Gastroenterol 35 Suppl 2 (2002) S138-S142
22. Levy I., and Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50 (2002) 881-885
23. Rabe C., Lenz M., Schmitz V., et al. An independent evaluation of modern prognostic scores in a central European cohort of 120 patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 15 (2003) 1305-1315
24. Ramacciato G., Mercantini P., Cautero N., et al. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 12 (2005) 289-297
25. Marrero J.A., Fontana R.J., Barrat A., et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 42 (2005) 707-716
26. Grieco A., Pompili M., Caminiti G., et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP and BCLC staging systems in a single Italian center. Gut 54 (2005) 411-418
27. Kattan M.W. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol 13 (2003) 111-116
28. Kattan M.W., Leung D.H., and Brennan M.F. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 20 (2002) 791-796
29. Kattan M.W., Karpeh M.S., Mazumdar M., and Brennan M.F. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21 (2003) 3647-3650
30. Brennan M.F., Kattan M.W., Klimstra D., and Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240 (2004) 293-298
31. Vauthey J.N., Klimstra D., Francheschi D., et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169 (1995) 28-35
32. Fong Y., Sun R.L., Jarnagin W., and Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229 (1999) 790-800
33. Cho C.S., Knechtle S.J., Heisey D.M., et al. Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. J Gastrointest Surg 5 (2001) 594-602
34. Nagasue N., Ono T., Yamanoi A., et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 88 (2001) 515-522
35. Poon R.T.P., Fan S.T., Lo C.M., et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234 (2001) 63-70
36. Poon R.T.P., Fan S.T., Lo C.M., et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235 (2002) 373-382
37. Ercolani G., Grazi G.L., Ravaioli M., et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 237 (2003) 536-543
38. Cha C., Fong Y., Jarnagin W.R., et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197 (2003) 753-758
39. Cha C.H., Ruo L., Fong Y., et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 238 (2003) 315-323
40. Liau K.H., Ruo L., Shia J., et al. Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 104 (2005) 1948-1955
41. Shah S.A., Greig P.D., Gallinger S., et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202 (2006) 275-283
42. Poon R.T., Fan S.T., Ng I.O., et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89 (2000) 500-507
43. Laurent C., Blanc J.F., Nobili S., et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 201 (2005) 656-662
44. Ng K.K., Vauthey J.N., Pawlik T.M., et al., International Cooperative Study Group on Hepatocellular Carcinoma. Is hepatic resection for large or multinodular hepatocellular carcinoma justified?. Results from a multi-institutional database. Ann Surg Oncol 12 (2005) 364-373
45. Portolani N., Coniglio A., Ghidoni S., et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243 (2006) 229-235